Children as young as six months old are now participating in a trial for Pfizer's COVID vaccine.
Children as young as six months old are now participating in a trial for Pfizer's COVID vaccine.
Moderna said Tuesday that Phase 2 trial results show that its COVID-19 vaccine is effective in adolescents aged 12 to 17.